de Wilde Adriaan H, Wannee Kazimier F, Scholte Florine E M, Goeman Jelle J, Ten Dijke Peter, Snijder Eric J, Kikkert Marjolein, van Hemert Martijn J
Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.
J Virol. 2015 Aug;89(16):8318-33. doi: 10.1128/JVI.01029-15. Epub 2015 Jun 3.
To identify host factors relevant for severe acute respiratory syndrome-coronavirus (SARS-CoV) replication, we performed a small interfering RNA (siRNA) library screen targeting the human kinome. Protein kinases are key regulators of many cellular functions, and the systematic knockdown of their expression should provide a broad perspective on factors and pathways promoting or antagonizing coronavirus replication. In addition to 40 proteins that promote SARS-CoV replication, our study identified 90 factors exhibiting an antiviral effect. Pathway analysis grouped subsets of these factors in specific cellular processes, including the innate immune response and the metabolism of complex lipids, which appear to play a role in SARS-CoV infection. Several factors were selected for in-depth validation in follow-up experiments. In cells depleted for the β2 subunit of the coatomer protein complex (COPB2), the strongest proviral hit, we observed reduced SARS-CoV protein expression and a >2-log reduction in virus yield. Knockdown of the COPB2-related proteins COPB1 and Golgi-specific brefeldin A-resistant guanine nucleotide exchange factor 1 (GBF1) also suggested that COPI-coated vesicles and/or the early secretory pathway are important for SARS-CoV replication. Depletion of the antiviral double-stranded RNA-activated protein kinase (PKR) enhanced virus replication in the primary screen, and validation experiments confirmed increased SARS-CoV protein expression and virus production upon PKR depletion. In addition, cyclin-dependent kinase 6 (CDK6) was identified as a novel antiviral host factor in SARS-CoV replication. The inventory of pro- and antiviral host factors and pathways described here substantiates and expands our understanding of SARS-CoV replication and may contribute to the identification of novel targets for antiviral therapy.
Replication of all viruses, including SARS-CoV, depends on and is influenced by cellular pathways. Although substantial progress has been made in dissecting the coronavirus replicative cycle, our understanding of the host factors that stimulate (proviral factors) or restrict (antiviral factors) infection remains far from complete. To study the role of host proteins in SARS-CoV infection, we set out to systematically identify kinase-regulated processes that influence virus replication. Protein kinases are key regulators in signal transduction, controlling a wide variety of cellular processes, and many of them are targets of approved drugs and other compounds. Our screen identified a variety of hits and will form the basis for more detailed follow-up studies that should contribute to a better understanding of SARS-CoV replication and coronavirus-host interactions in general. The identified factors could be interesting targets for the development of host-directed antiviral therapy to treat infections with SARS-CoV or other pathogenic coronaviruses.
为了确定与严重急性呼吸综合征冠状病毒(SARS-CoV)复制相关的宿主因子,我们针对人类激酶组进行了小干扰RNA(siRNA)文库筛选。蛋白激酶是许多细胞功能的关键调节因子,对其表达进行系统性敲低应能为促进或拮抗冠状病毒复制的因子和途径提供广泛的视角。除了40种促进SARS-CoV复制的蛋白质外,我们的研究还鉴定出90种具有抗病毒作用的因子。通路分析将这些因子的子集归类于特定的细胞过程,包括先天免疫反应和复合脂质代谢,这些过程似乎在SARS-CoV感染中发挥作用。在后续实验中选择了几种因子进行深入验证。在衣被蛋白复合物(COPB2)的β2亚基缺失的细胞中,这是最强的促病毒靶点,我们观察到SARS-CoV蛋白表达降低,病毒产量降低了超过2个对数。敲低与COPB2相关的蛋白COPB1和高尔基体特异性布雷菲德菌素A抗性鸟嘌呤核苷酸交换因子1(GBF1)也表明,COPI包被的囊泡和/或早期分泌途径对SARS-CoV复制很重要。在初次筛选中,抗病毒双链RNA激活蛋白激酶(PKR)的缺失增强了病毒复制,验证实验证实PKR缺失后SARS-CoV蛋白表达和病毒产生增加。此外,细胞周期蛋白依赖性激酶6(CDK6)被鉴定为SARS-CoV复制中的一种新型抗病毒宿主因子。本文描述的促病毒和抗病毒宿主因子及途径的清单证实并扩展了我们对SARS-CoV复制的理解,并可能有助于确定抗病毒治疗的新靶点。
包括SARS-CoV在内的所有病毒的复制都依赖于细胞途径并受其影响。尽管在剖析冠状病毒复制周期方面取得了重大进展,但我们对刺激(促病毒因子)或限制(抗病毒因子)感染的宿主因子的理解仍远未完善。为了研究宿主蛋白在SARS-CoV感染中的作用,我们着手系统地鉴定影响病毒复制的激酶调节过程。蛋白激酶是信号转导中的关键调节因子,控制着多种细胞过程,其中许多是已批准药物和其他化合物的靶点。我们的筛选鉴定出了多种靶点,将为更详细的后续研究奠定基础,这些研究应有助于更好地理解SARS-CoV复制以及一般的冠状病毒-宿主相互作用。所鉴定的因子可能是开发针对宿主的抗病毒疗法以治疗SARS-CoV或其他致病性冠状病毒感染的有趣靶点。